| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Collegium Pharmaceutical, Inc. (COLL) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 17 sells. COLL is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 3.13M | $109.24M | - | |
| CFO | 126.7K | $4.42M | - | |
| VP | 121.2K | $4.23M | - | |
| CEO | 97.0K | $3.38M | - | |
| Dir | 95.0K | $3.31M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 13, 2020 | Dreyer Scott54 | EVP &Chief Commercial Officer | Sell | 1,429 | $17.01 | $24,307.29 | -3.0% | |
| Jun 2, 2020 | Ciaffoni Joseph | President And CEO | Sale+OE | 76,537 | $21.45 | $1,641,766.95 | -8.9% | |
| May 18, 2020 | Dreyer Scott54 | EVP &Chief Commercial Officer | Sale+OE | 8,000 | $24.00 | $192,000.00 | -14.2% | |
| May 13, 2020 | Heffernan Michael Thomas | Director | Sell | 19,254 | $21.63 | $416,421.29 | -6.7% | |
| May 13, 2020 | Fleming Alison B | Chief Technology Officer | Sell | 7,989 | $21.67 | $173,147.04 | -3.7% | |
| May 13, 2020 | Dreyer Scott54 | EVP &Chief Commercial Officer | Sell | 4,434 | $22.61 | $100,252.74 | -8.4% | |
| Jan 21, 2020 | Heffernan Michael Thomas | Director | Sale+OE | 295,287 | $21.93 | $6,476,863.08 | -54.5% | |
| Jan 14, 2020 | Dreyer Scott54 | EVP &Chief Commercial Officer | Sell | 1,321 | $23.87 | $31,532.27 | -3.6% | |
| Nov 8, 2019 | Hirsch David | Director | Sell | 25,000 | $19.33 | $483,250.00 | -59.4% | |
| Nov 8, 2019 | Fleming Alison B | Chief Technology Officer | Sale+OE | 25,000 | $19.44 | $486,000.00 | -25.4% |